19q缺失星形细胞瘤的基因表达谱提示与较好预后相关的特定模式
本研究比较5例19q缺失与5例19q完整IDH突变星形细胞瘤的基因表达谱,发现102个上调基因和162个下调基因,下调基因富集于19q和4p,上调基因富集于4q。19q缺失星形细胞瘤中干细胞维持相关FGF1及多个胶质瘤进展相关基因下调,TCGA数据验证显示其表达模式未向1p/19q共缺失少突胶质细胞瘤偏移,而是构成星形细胞瘤亚组。
要点
- 19q缺失IDH突变星形细胞瘤具有独特基因表达模式,可能为独立亚组。
- 下调基因富集于19q和4p,上调基因富集于4q。
- FGF1及胶质瘤进展相关基因下调,经TCGA数据验证。
核心结论
- 19q缺失在星形细胞瘤中更可能是后天获得事件而非癌变早期事件,其生物学特征可能与干细胞维持和胶质瘤进展相关基因的差异表达有关。
研究设计与样本
- 研究比较5例19q缺失与5例19q完整IDH突变星形细胞瘤的基因表达谱,采用微阵列分析,并利用独立TCGA数据集验证。
主要发现
- 与19q完整星形细胞瘤相比,19q缺失星形细胞瘤中提取出102个上调基因和162个下调基因。
- 下调基因主要富集于19q和4p,上调基因主要富集于4q。
- 干细胞维持相关FGF1及多个胶质瘤进展相关基因在19q缺失星形细胞瘤中下调,并经TCGA数据验证。
- t-SNE分析显示19q缺失星形细胞瘤表达模式未向1p/19q共缺失少突胶质细胞瘤偏移,而是构成星形细胞瘤亚组。
临床怎么用
- 对于IDH突变星形细胞瘤,检测19q缺失可能有助于识别具有较好预后的亚组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We previously reported that there was a subgroup of IDH-mutated astrocytomas harboring only 19q-loss showing oligodendroglioma-like morphology and significantly longer overall survival (OS) compared with 19q-intact astrocytomas. The aim of this study was to further explore the biological characteristics of this possible subgroup and obtain insight into the mechanism of their relatively benign clinical behavior. METHODS: We compared gene expression pattern between five 19q-loss and five 19q-intact IDH-mutated astrocytomas by microarray analysis. RESULTS: By comparing expression levels of genes of 19q-loss astrocytomas to those of 19q-intact astrocytomas, 102 up-regulated genes and 162 down-regulated genes were extracted. The down-regulated genes clustered heavily to 19q and 4p while the up-regulated genes clustered to 4q. It was noteworthy that fibroblast growth factor 1 associated with stem cell maintenance and multiple genes associated with glioma progression were down-regulated in 19q-loss astrocytomas, and these results were validated with the independent TCGA data set. On t-SNE analysis of the 19q-loss astrocytomas with other IDH-mutant glioma subgroups from the TCGA datasets, the expression pattern of the 19q-loss astrocytomas showed no shift toward oligodendrogliomas with 1p/19q codeletion but rather constituted a subgroup of astrocytoma. CONCLUSIONS: These findings suggested that 19q-loss in astrocytomas is more likely acquired event rather than an early event in oncogenesis like the 1p/19q-codeletion in oligodendrogliomas, and that the biological features of 19q-loss astrocytomas are possibly related to differentially expressed genes associated with stem cell maintenance and glioma progression.
引用
- Otani R, Mukasa A, Uzuka T, et al. Gene expression profiling of 19q-loss astrocytomas suggest a specific pattern associated with the better prognosis. J Neurooncol. 2021. PMID: 34328582. doi:10.1007/s11060-021-03816-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。